InvestorsHub Logo
Followers 21
Posts 1996
Boards Moderated 0
Alias Born 11/26/2014

Re: 123414 post# 3654

Monday, 10/07/2019 7:47:27 AM

Monday, October 07, 2019 7:47:27 AM

Post# of 4163
The Company anticipates that patient enrollment and treatment will escalate rapidly with the increased momentum as it launches additional clinical study sites, as UHN has now treated its second patient.



https://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=7166363967422512&topic=TLTFF&symbology=null&cp=null&webmasterId=90338


JMO, maybe, maybe not.